Skip to content
  • Tuesday, 27 October 2026
  • 7:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent
Laboratory Automation & Robotics

Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent

Lana Keisha Oct 16, 2026 0

The integration of artificial intelligence into the pharmaceutical industry has reached a critical inflection point, as a new collaborative analysis…

Read More
Laboratory Automation & Robotics

Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent

Lana Keisha Oct 8, 2026 0

The landscape of clinical drug development is undergoing a paradigm shift as the integration of agentic artificial intelligence (AI) moves…

Read More
Laboratory Automation & Robotics

Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent

Lana Keisha Sep 30, 2026 0

The integration of artificial intelligence into clinical research has reached a critical inflection point, moving beyond experimental pilot programs to…

Read More
Laboratory Automation & Robotics

Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent

Lana Keisha Sep 22, 2026 0

The integration of artificial intelligence into the pharmaceutical industry has reached a critical inflection point, moving beyond theoretical experimentation into…

Read More
Laboratory Automation & Robotics

Tufts model estimates 82x ROI and up to $21 million in value from Medable AI agent

Lana Keisha Sep 13, 2026 0

The integration of artificial intelligence into the pharmaceutical industry has reached a critical inflection point, as a new collaborative analysis…

Read More
Research Team Uncovers Breakthrough Evidence of Heart Muscle Regeneration in Patients with Artificial HeartsCornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male ContraceptionTWiV 1286: Clinical update with Dr. Daniel GriffinOsaka University Researchers Identify Key Protein Interaction Regulating Sperm Development and Male Fertility
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The Roadmap to Becoming a Computer Vision Engineer in 2026: Mastering Spatial Computing, Foundation Models, and Edge DeploymentThe Hidden Hammer: How Volcanic Eruptions Have Silently Shaped the Course of Human HistoryNavigating the Critical Transition from Laboratory Bench to GMP Fill-Finish CDMO OperationsMicroscopic Magnetic Vortices Called Skyrmions Could Pave the Way for Brain-Like Computers Operating on a Fraction of Modern Energy Consumption
YOU MAY HAVE MISSED
Data Science & Bioinformatics
The Roadmap to Becoming a Computer Vision Engineer in 2026: Mastering Spatial Computing, Foundation Models, and Edge Deployment
Evan Lee Salim Oct 27, 2026
Environmental & Analytical Chemistry
The Hidden Hammer: How Volcanic Eruptions Have Silently Shaped the Course of Human History
Abdurrohim Arsyad Oct 27, 2026
Pharmaceutical R&D
Navigating the Critical Transition from Laboratory Bench to GMP Fill-Finish CDMO Operations
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Microscopic Magnetic Vortices Called Skyrmions Could Pave the Way for Brain-Like Computers Operating on a Fraction of Modern Energy Consumption
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ